Support with the BVS® 5000 assist device during treatment of acute giant-cell myocarditis

Texas Heart Institute Journal

Volumn 30, Issue 1, 2003, Pages 50-56

  Marelli, Daniel ^a,b   Kermani, Reza ^a   Bresson, Jessica ^a   Fishbein, Michael C ^a   Hamilton, Michele ^a   Moriguchi, Jaime ^a   Fonarow, Gregg C ^a   Cohen, Benjamin ^a   Kobashigawa, Jon ^a   Laks, Hillel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Autoimmune diseases; Giant cells; Heart transplantation; Heartassist devices; Myocarditis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; INOTROPIC AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AORTA BALLOON; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; FEBRILE NEUTROPENIA; FEMALE; GIANT CELL; GRAFT REJECTION; HEART ASSIST DEVICE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMATOTHORAX; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTATION; LEUKOPENIA; LONG TERM CARE; MALE; MULTIPLE ORGAN FAILURE; MYOCARDITIS; STERNOTOMY; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0037219371     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997;336(26):1860-6.
2. Gries W, Farkas D, Winters GL, Costanzo-Nordin M. Giant cell myocarditis: first report of disease recurrence in the transplanted heart. J Heart Lung Transplant 1992;11(2 Pt 2):370-4.
3. Marelli D, Laks H, Amsel B, Jett GK, Couper G, Ardehali A, et al. Temporary mechanical support with the BVS 5000 assist device during treatment of acute myocarditis. J Card Surg 1997;12:55-9.
4. Marelli D, Laks H, Fazio D, Hamilton MA, Fonarow GC, Meehan DA, Mariguchi JD. Mechanical assist strategy using the BVS 5000i for patients with heart failure. Ann Thorac Surg 2000;70:59-66.
5. Champsaur G, Ninet J, Vigneron M, Cochet P, Neidecker J, Boissonnat P. Use of the Abiomed BVS System 5000i as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1990;100:122-8.
6. Jett GK. ABIOMED BVS 5000. Experience and potential advantages. Ann Thorac Surg 1996;61:301-4,311-3.
7. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 1994;75(2):278-84.
8. Hanawa H, Inomata T, Okura Y, Hirono S, Ogawa Y, Izumi T, et al. T cells with similar T-cell receptor beta-chain complementarity-determining region 3 motifs infiltrate inflammatory lesions of synthetic peptides inducing rat autoimmune myocarditis. Circ Res 1998;83(2):133-40.
9. Cooper LT Jr. Giant cell myocarditis: diagnosis and treatment. Herz 2000;25(3):291-8.
10. Nieminen MS, Salminen US, Taskinen E, Heikkila P, Partanen J. Treatment of serious heart failure by transplantation in giant cell myocarditis diagnosed by endomyocardial biopsy. J Heart Lung Transplant 1994;13:543-5.
11. Brilakis ES, Olson LJ, Berry GJ, Daly RC, Loisance D, Zucker M, Cooper LT Jr. Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices. ASAIO J 2000;46(5):569-72.
12. Tsai FC, Marelli D, Laks H, Moriguchi J, Sopher M, Bresson J, et al. Short-term bridge to heart transplant using the BVS 5000 external ventricular assist device. Am J Transplant 2002;2(7):646-51.
13. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
14. Frustaci A, Chimenti C, Pieroni M, Gentiloni N. Giant cell myocarditis responding to immunosuppressive therapy. Chest 2000;117(3):905-7.